We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.435 | 0.29% | 149.015 | 149.73 | 148.89 | 149.38 | 1,742,731 | 17:20:37 |
From May 2019 to May 2024
By Josh Beckerman
Johnson & Johnson said it remains committed to supplying 200 million doses of its Covid-19 vaccine to the European Union, Norway and Iceland.
Earlier Tuesday, the European Medicines Agency called for a warning about very rare blood clots but said the benefits of the vaccine outweigh the risks.
J&J said it will update the Summary of Product Characteristics and Package Leaflet. "Healthcare professionals will be alerted to the signs and symptoms of thromboembolism with thrombocytopenia, as well as the appropriate course of treatment," the company said.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
April 20, 2021 12:36 ET (16:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
